financetom
Business
financetom
/
Business
/
Big Deal: How special situation funds can help provide capital during COVID-19 crisis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Big Deal: How special situation funds can help provide capital during COVID-19 crisis
Apr 16, 2020 11:53 AM

As the global crisis situation deepens and the Indian lockdown continues, companies are expected to be in deeper trouble and stressed assets are also expected to loom large.

Now at a time when the banks as well as the NBFCs could be saddled with a huge amount of asset quality deterioration, there needs to be more forms of funding.

A specialised area, or the pocket of investors known as stress funds, which also fall under the broad ambit of special situation funds, could play a big role here.

CNBC-TV18’s Nisha Poddar talked to Venkat Ramaswamy, VC of Edelweiss Financial Services and Srini Sriniwasan, MD of Kotak Alternate Assets, who are focused on this business.

First Published:Apr 16, 2020 8:53 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ATS Receives Approval From TSX for Normal Course Issuer Bid
ATS Receives Approval From TSX for Normal Course Issuer Bid
Mar 10, 2026
08:39 AM EST, 12/18/2025 (MT Newswires) -- ATS (TSX and NYSE: ATS) on Thursday said that the Toronto Stock Exchange approved the company's notice of intention to make a normal course issuer bid (NCIB). Under the bid, the company will have the ability to buy back for cancellation up to a maximum of 8.2-million common shares, about 10% of the...
CAMP4 Therapeutics, GSK Collaborate to Develop RNA-Based Therapeutics for Neurodegenerative and Kidney Diseases
CAMP4 Therapeutics, GSK Collaborate to Develop RNA-Based Therapeutics for Neurodegenerative and Kidney Diseases
Mar 10, 2026
08:38 AM EST, 12/18/2025 (MT Newswires) -- CAMP4 Therapeutics ( CAMP ) said Thursday it has entered a research, collaboration and license agreement with GSK (GSK) to identify and develop antisense oligonucleotide drug candidates targeting neurodegenerative and kidney disease indications. Under the agreement, CAMP4 Therapeutics ( CAMP ) will receive upfront cash payment of $17.5 million and is eligible for...
Cybin to Transfer Listing to Nasdaq From NYSE American
Cybin to Transfer Listing to Nasdaq From NYSE American
Mar 10, 2026
08:39 AM EST, 12/18/2025 (MT Newswires) -- Cybin ( CYBN ) said Thursday that it will voluntarily transfer its listing to the Nasdaq Global Market from the NYSE American. Cybin ( CYBN ) said it expects its common shares will cease trading at the NYSE American at market close on Jan. 4 and start trading on Nasdaq at market open...
Alight Appoints Greg Giometti as Interim Chief Financial Officer
Alight Appoints Greg Giometti as Interim Chief Financial Officer
Mar 10, 2026
08:38 AM EST, 12/18/2025 (MT Newswires) -- Alight (ALIT) said Thursday it has appointed Greg Giometti as the company's interim chief financial officer, effective Jan. 9, 2026. Giometti succeeds Jeremy Heaton, who will depart Alight to pursue another opportunity, the company said. Giometti joined Alight in 2020 and currently serves as the company's senior vice president, head of financial planning...
Copyright 2023-2026 - www.financetom.com All Rights Reserved